摘要 |
This invention concerns the use of a compound of formula (I') a N-oxide, pharmaceutically acceptable addition salt, quaternary amine and stereochemically isomeric form thereof, wherein Q is optionally substituted C<SUB>3-6</SUB>cycloalkyl, phenyl, naphthyl, pyridyl, pyrimidinyl, pyrazinyl, pyridazinyl, benzthiazolyl, benzoxazolyl, benzimidazolyl, indazolyl, or imidazopyridyl; or Q is a radical of formula wherein X and Y each independently are O, NR<SUP>3</SUP>, CH<SUB>2 </SUB>or S, with R<SUP>3 </SUP>being hydrogen or C<SUB>1-4</SUB>alkyl; q is 1 to 4; Z is O or NR<SUP>4 </SUP>with R<SUP>4 </SUP>being hydrogen or C<SUB>1-4</SUB>alkyl; r is 1 to 3; L is optionally substituted phenyl or L is Het with Het being an optionally substituted five- or six-membered heterocyclic ring or an optionally substituted bicyclic heterocyclic ring; for the manufacture of a medicament for the prevention or the treatment of diseases mediated through cytokines.
|